This video is sponsored by the Duke Clinical Medical Series.
Peter Berger, MD has indicated that the presentation does not include discussion of any
off-label, experimental and/or investigational uses of drugs or devices. The moderator,
Peter Berger, MD, has indicated that he receives research/grant support from Aventis,
Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an advisory board
for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific symposia for
Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also serves as Medical
Director and has equity with Lumen, Inc.
The guest, Stephen Ellis, MD, has indicated that he has nothing to disclose with regard to
this CME activity.
|
|